CNMD — CONMED Corp
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 816956 ·
Last close
$36.06
Market Cap
$1.09B
52W High
$46.55
52W Low
$33.21
ADV30
433,521
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 317,046,000 | 183,447,000 | 25,415,000 | 13,828,000 | 2,314,942,000 | 35,030,000 | 1,297,269,000 |
| Dec 2025 | 373,198,000 | 218,285,000 | 36,624,000 | 16,739,000 | 2,325,749,000 | 40,817,000 | 1,292,652,000 |
| Sep 2025 | 337,926,000 | 166,119,000 | 11,879,000 | 2,859,000 | 2,322,488,000 | 38,929,000 | 1,314,225,000 |
| Jun 2025 | 342,345,000 | 188,320,000 | 38,161,000 | 21,421,000 | 2,328,458,000 | 33,935,000 | 1,325,588,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$142,627,000
Investing CF
$-13,919,000
Financing CF
$-129,975,000
CapEx
$-18,919,000
Dividends Paid
$-18,566,000
Buybacks
$-37,017,000
EPS Diluted TTM
$1.77
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$602,594,000
Inventory
$366,106,000
Receivables
$228,661,000
ST Investments
—
EBIT TTM
$111,661,000
Pretax Income TTM
$81,800,000
Interest Exp TTM
$29,861,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,370,514,048
EBITDA
$210,655,008
Free Cash Flow
$125,867,624
Enterprise Value
$1,946,803,328
Total Cash
$35,030,000
Total Debt
$860,867,968
Shares Out
30,109,194
Trailing EPS
$1.77
Book Value
$33.76
ROE
5.5%
ROA
3.7%
Div Yield
2.15%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,374,724,000 | 102,622,000 | 47,055,000 | 2,325,749,000 | 1,292,652,000 | — | 170,689,000 |
| Dec 2024 | 1,307,015,000 | 200,326,000 | 132,423,000 | 2,306,247,000 | 1,343,566,000 | — | 166,968,000 |
| Dec 2023 | 1,244,744,000 | 120,603,000 | 64,459,000 | 2,300,021,000 | 1,465,799,000 | — | 125,348,000 |
| Dec 2022 | 1,045,472,000 | 70,054,000 | -80,582,000 | 2,297,592,000 | 1,552,047,000 | — | 33,365,000 |
TTM Snapshot
Revenues TTM
$1,145,194,000
NetIncome TTM
$125,919,000
OpCashFlow TTM
$0
Assets (Latest)
$2,306,247,000
Forward EPS
$4.85
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BFLY | Butterfly Network, Inc. | $1.07B | $4.54 | — |
| AORT | ARTIVION, INC. | $1.13B | $23.19 | — |
| AVNS | AVANOS MEDICAL, INC. | $1.16B | $24.75 | — |
| BLFS | BIOLIFE SOLUTIONS INC | $1.17B | $24.03 | — |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $1.18B | $15.19 | — |
News headlines (Yahoo Finance, 1h cache)
Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?
2026-05-25 15:15 · Yahoo
CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors
2026-05-20 12:30 · Yahoo
[Latest] Global Orthopedic Soft Tissue Repair Market Size/Share Worth USD 15.38 Billion by 2035 at a 9.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation
2026-05-18 12:30 · Yahoo
Is the Options Market Predicting a Spike in CONMED Stock?
2026-05-14 14:58 · Yahoo
[Latest] Global Flexible Endoscope Market Size/Share Worth USD 22.7 Billion by 2035 at a 6% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate
2026-05-11 17:30 · Yahoo
Does CONMED (CNMD) Refocusing Away From Gastroenterology Clarify Its Long-Term Surgical Growth Story?
2026-05-05 00:18 · Yahoo
Assessing CONMED (CNMD) Valuation After A Mixed Stretch In Recent Share Performance
2026-05-04 14:11 · Yahoo
Is CONMED Corporation (CNMD) A Good Stock To Buy Now?
2026-05-03 18:43 · Yahoo
CNMD Q1 Deep Dive: GI Exit Refocuses Growth on Core Surgical Platforms
2026-05-02 04:28 · Yahoo
CONMED Corporation Q1 2026 Earnings Call Summary
2026-04-30 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.